Abstract
Introduction Drug-related problem is any event involving drug therapy that interferes with a patient’s desired clinical outcome. Hospitalized pediatric patients are particularly prone to drugrelated problems. Thus, this study aimed to assess drug-related problems and associated factors among patients admitted to the pediatric ward of the University of Gondar Comprehensive and Specialized Hospital, Ethiopia.
Methods A hospital-based cross-sectional study was conducted among pediatric patients admitted to the University of Gondar Comprehensive and Specialized Hospital from May 1, to July 30, 2021. A Simple random sampling technique was employed to select study participants. Odds ratio with 95% confidence interval was computed for each variable for the corresponding P-value to see the strength of association. Those variables which have a P-value of < 0.25 in Bivariable analysis were entered in Multivariable analysis to determine factors associated with drug related problems.
Results A total of 180 drug-related problems were identified in 145 participants with an overall prevalence of 40.2% [95% CI (35.5-45.4)]. Dose too low (35.56%), needs additional drug (28.89%) and dose too high (21%) were the commonest type of drug-related problems identified. The most important interventions made were dose adjustment (52%) and the addition of drugs (30%). The presence of comorbidity [AOR = 3.32, 95% CI (1.88-5.88)], polypharmacy [AOR = 4.22, 95% CI (2.21-8.10)], and more than 6 days stay in the hospital [AOR =7.59, 95% CI (3.76-15.33)] were independent predictors for the occurrence of drug-related problems.
Conclusion Drug-related problems are common among hospitalized pediatrics at the University of Gondar Comprehensive and Specialized Hospital. The presence of comorbidity, polypharmacy and prolonged hospital stay were predictors of drug-related problems. Therefore, health care providers have to work in collaboration with clinical pharmacists and give due attention to those patients with comorbidity, polypharmacy and patients who stayed longer days in the hospital.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Amhara regional health beaurou funded this study as graduate research. The funder has no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical clearance was obtained from the ethical review committee of department of clinical Pharmacy, Gondar University, and permission was also obtained from University of Gondar Comprehensive and Specialized Hospital and unit officials to conduct this study
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
